[Anticoagulant therapy with "regulated hypocoagulation of the blood" in the initial period of myocardial infarct].
D001780:Blood Coagulation Tests; D004341:Drug Evaluation; D005017:Ethyl Biscoumacetate / Q000627:therapeutic use*; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010958:Plasminogen / Q000032:analysis; D013917:Thrombin / Q000032:analysis; D013997:Time Factors
D005017:Ethyl Biscoumacetate; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D013917:Thrombin; D005341:Fibrinolysin
Antikoaguliantnaia terapiia s "upravliaemoĭ gipokoaguliatsieĭ krovi" v nachal'nom periode infarkta miokarda